Indivior Pharmaceuticals, Inc. (INDV)

33.36 +1.13 (+3.51%) USD  |  NASDAQ  |  Apr 22, 13:43
More

Indivior Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for INDV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Pulse Biosciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade